Medicines manufacturer and supplier Morningside Pharmaceuticals has appointed a new Chief Executive Officer (CEO) and Chairman to oversee the company’s governance. The Executive Team and Group Board will be responsible for enhancing internal and external systems and processes, as well as delivering the business’ ambitious growth plans for the future....
VITMEDICS WINS MAJOR INTERNATIONAL AWARD FOR ON-LINE PERSONALISED NUTRITION INITIATIVE
A Medilink East Midlands business headed by pharmacist and specialist in nutritional medicine, Michael Wakeman, is celebrating victory in the prestigious International Nutraingredients award for an on-line personalised nutrition initiative www.vitmedics.com, which also coincides with the publication of its’ book -Medicated malnourishment. The initiative is the culmination of his research...
The UK life sciences market after December 2020 – clinical trials
UK Government has issued new Brexit guidance for the life sciences sector. With the transition period coming to an end on 31 December, only three months remain before the Medicines and Healthcare products Regulatory Agency (MHRA) takes on its role as the UK’s standalone medicines and medical devices regulator. In...
Finalists Shortlisted for Medilink UK Business Awards
A selection of the best and brightest talents in life sciences have been shortlisted for the national Medilink UK Healthcare Business Awards 2020, sponsored by Grant Thornton LLP. Over 40 companies encompassing the length and breadth of the life sciences sector will come together on Thursday, October 8 and five...
CEO of Spirit Health Group named among UK’s Top 50 Most Ambitious Business Leaders
Chris Barker, CEO & Chief Mischievist of Spirit Health Group has been named as one of LDC’s Top 50 Most Ambitious Business Leaders for 2020. Now in its third year, the programme, which is supported by The Telegraph, celebrates the inspiring leaders behind some of the UK’s most successful and...
A major new health study is to be launched in a bid to help millions who suffer from ‘dry eye’
One in four of us will suffer from the debilitating condition with symptoms ranging from sore eyes through to short-term blurred vision. Now experts based in Birmingham and Nottingham are looking for people to take part in the study, wearing a special contact lens for under 2 weeks, which could...
Worried About Brexit Trading Unknowns?
Here’s How Addressing the Known Knowns Can Really Help As the post-Brexit EU trade deal negotiations continue into the Autumn, and we come to the end of the Transition Period on December 31, UK businesses must prepare. Department for International Trade (DIT) Export Champion and Chief Executive of Morningside Pharmaceuticals,...
Pennine Healthcare launches two new products in the fight against COVID-19
The UK manufactured Face Coverings and Sanitiser Stations will be sold on Pennine’s e-commerce site, ARMA Health. Pennine Healthcare, one of the UK’s leading privately-owned medical manufacturers, is delighted to announce the launch of two new UK manufactured products, Face Coverings and Sanitiser Stations, to help in the fight against...
Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis
Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has significantly expanded its DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical DMPK, quantitative bioanalysis, in vitro pharmacology and expert interpretation. This latest acquisition by Sygnature – which has in...
PHARMASEAL’s £1million crowdfunding campaign gains momentum
A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone. Launched by the new provider of clinical trial management and governance solutions last month, the campaign is aimed at raising capital in order to continue its journey using...
